 PHILADELPHIA, PA, March 03, 2021 GLOBE NEWSWIRE -- Vallon Pharmaceuticals Inc. NASDAQ: VLON, Vallon or the Company, a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment of CNS disorders, announced today that David Baker, President Chief Executive Officer of Vallon will present at the virtual H.C. Wainwright Global Life Sciences Conference, which is taking place March 9 and 10, 2021. 